EP-1166 Lipopolysacharide-binding protein in biodosimetry during radiotherapy for lung cancer

J. Chalubinska-Fendler, W. Fendler, J. Luniewska-Bury, E. Polakowska, K. Wyka, J. Fijuth
2015 Radiotherapy and Oncology  
S634 3rd ESTRO Forum 2015 to sPTV. The mean V20 values was 7.8% for dynamic tracking SBRT (tV20) and 8.1% for static SBRT (sV20), corresponding to an average reduction of 11.2 ± 5.9% (p = 0.016) in the tV20 compared to sV20. Conclusions: This study demonstrates that lung SBRT with DTT reduces treatment volumes and dose to normal lung tissue. Further clinical outcome data are required to validate these findings.
doi:10.1016/s0167-8140(15)41158-2 fatcat:6gzwza3eibayzhfw7e44wa3g3m